346 top medical experts on Adrenoleukodystrophy across 43 countries and 28 U.S. states, including 196 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Adrenoleukodystrophy: An X-linked recessive disorder characterized by the accumulation of saturated very long chain fatty acids in the lysosomes of adrenal cortex and the white matter of central nervous system. This disease occurs almost exclusively in the males. Clinical features include the childhood onset of ataxia; neurobehavioral manifestations; hyperpigmentation; adrenal insufficiency; seizures; muscle spasticity; and dementia. The slowly progressive adult form is called adrenomyeloneuropathy. The defective gene abcd1 is located at Xq28, and encodes the adrenoleukodystrophy protein (ATP-binding cassette transporters).
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): X-Linked Mental Retardation (2,803), Inborn Metabolic Brain Diseases (1,358), Hereditary Central Nervous System Demyelinating Diseases (1,644), Peroxisomal Disorders (437), Adrenal Insufficiency (1,518).
  4. Clinical Trials ClinicalTrials.gov : at least 50 including 5 Active, 14 Completed, 13 Recruiting
  5. Synonyms: Adrenomyeloneuropathy,  Schilder-Addison Complex,  X-Linked Adrenoleukodystrophy


  

        

                    


    Computing Expert Listing ...

);